The first step in the adjudication process was to decide whether there was syncope or not. If the criteria for a true syncope were not fulfilled, a distinction between the following non-syncopal disorders was made: pre-syncope; falls; stroke/TIA; epilepsy; metabolic disorders: e.g. hypoglycaemia, hypoxia, hyperventilation; intoxication: e.g. alcohol, benzodiazepines, opiates; functional (psychogenic pseudosyncope); others.
metabolic disorders: e.g. hypoglycaemia, hypoxia, hyperventilation; intoxication: e.g. alcohol, benzodiazepines, opiates; functional (psychogenic pseudosyncope); others.
The classification of syncope is based on pathophysiological considerations. The following predefined differential diagnoses were used: b. Structural heart disease: structural heart diseases can cause syncope when circulatory demands outweigh the impaired ability of the heart to increase output. However, in some cases syncope may not solely be the result of restricted cardiac output, but be in part due to an inappropriate reflex. However, when a structural heart disease was the primary cause or contributed most to syncope, it was classified as cardiovascular syncope. c. Others: pulmonary embolism, acute aortic dissection, pulmonary hypertension or any other cause for a cardiovascular syncope. On what basis potentially eligible participants were identified 5 (such as symptoms, results from previous tests, inclusion in registry) 8
Where and when potentially eligible participants were identified (setting, 5 location and dates) 9
Whether participants formed a consecutive, random or convenience series 5 Test methods 10 Index test, in sufficient detail to allow replication 6-7 11
Reference standard, in sufficient detail to allow replication 6-7 12
Rationale for choosing the reference standard (if alternatives exist) 6-7 13
Definition of and rationale for test positivity cut-offs or result categories of the index test, distinguishing pre-specified from exploratory %  225  21  1  2  1  0  0  0  0  0  10  3  68  17  3  1  3  0  0  0  1  29  0  3  44  10  2 Net reclassification improvement focuses on reclassification tables constructed separately for participants without events (non-cardiac syncope) and patients with events (cardiac syncope), and quantifies the balance between correct movements in categories (upwards for events and downwards for non-events) and incorrect movements (downwards for events and upwards for non-events)
The biggest incremental value of MRproANP is seen in patients with intermediate risk of cardiac syncope, determined by the ED-physician with a visual analogue score (VAS) ranging between 21%-80%. In patients with non-cardiac syncope, 31 (5.5%) correctly moved downward in the classification and 38 patients (6.7%) incorrectly moved upward. In patients with cardiac syncope, 26 patients (21%) correctly moved upwards and 2 (1.6%) incorrectly moved downward in the classification.
The net reclassification improvement was calculated at 0.216 (p<0.001). Integrated discriminatory improvement (IDI) was 0.035 (p=0.001). Table S5 . Overview of patients with low initial ED-probability (VAS-Score ≤20%) and a final diagnosis of cardiac syncope
